Pluri Inc. (PLUR): Net Income
-$23.82M
Year ended 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$23.82M | n/m | 2026-09-10, From 2025-07-01 |
| 2025-06-30 | -$22.58M | n/m | 2026-09-10, From 2024-07-01 |
| 2024-06-30 | -$20.89M | n/m | 2025-09-17, From 2023-07-01 |
| 2023-06-30 | -$28.32M | n/m | 2024-09-18, From 2022-07-01 |
| 2022-06-30 | -$41.24M | n/m | 2023-09-12, From 2021-07-01 |
| 2021-06-30 | -$49.87M | n/m | 2022-09-21, From 2020-07-01 |
| 2020-06-30 | -$29.15M | n/m | 2021-09-13, From 2019-07-01 |
| 2019-06-30 | -$35.31M | n/m | 2020-09-10, From 2018-07-01 |
| 2018-06-30 | -$26.13M | n/m | 2020-09-10, From 2017-07-01 |
| 2017-06-30 | -$27.81M | n/m | 2019-09-12, From 2016-07-01 |
| 2016-06-30 | -$23.25M | n/m | 2018-09-12, From 2015-07-01 |
| 2015-06-30 | -$24.68M | n/m | 2017-09-07, From 2014-07-01 |
| 2014-06-30 | -$26.93M | n/m | 2016-09-07, From 2013-07-01 |
| 2013-06-30 | -$21.16M | n/m | 2015-09-09, From 2012-07-01 |
| 2012-06-30 | -$14.79M | n/m | 2014-09-11, From 2011-07-01 |
| 2011-06-30 | -$10.85M | n/m | 2013-09-11, From 2010-07-01 |
| 2010-06-30 | -$7.45M | n/a | 2012-09-10, From 2009-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Pluri Inc. (PLUR) | 2026-06-30 | -$23.82M | n/m |
| Prokidney Corp. (PROK) | 2025-12-31 | -$151.61M | n/m |
| ImageneBio, Inc. (IMA) | 2025-12-31 | -$45.35M | n/m |
| Inhibrx Biosciences, Inc. (INBX) | 2025-12-31 | -$140.06M | n/m |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | -$8.31M | n/m |
| Outlook Therapeutics, Inc. (OTLK) | 2025-09-30 | -$62.42M | n/m |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | -$45.85M | n/m |
| Humacyte, Inc. (HUMA) | 2025-12-31 | -$40.83M | n/m |
| Aligos Therapeutics, Inc. (ALGS) | 2025-12-31 | -$24.19M | n/m |
Compare PLUR, PROK, IMA, INBX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗